Katica Schwarz
Schering AG
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Katica Schwarz.
Steroids | 1992
Andreas Steinmeyer; Günter Neef; Gerald Kirsch; Katica Schwarz; Petra Rach; Martin Haberey; Ruth Thieroff-Ekerdt
8(14)a-Homocalcitriol was synthesized and tested for its biologic activities. It exhibited a vitamin D agonist activity profile. The compound was bound to the pig intestinal receptor with an affinity slightly less than calcitriol, showed the same potency in inducing HL 60 cell differentiation and inhibition of keratinocyte proliferation as calcitriol, and was found to be approximately 10-fold less potent in inducing hypercalcemia and hypercalciuria after a single injection in normal rats.
Steroids | 2001
Andreas Steinmeyer; Katica Schwarz; Martin Haberey; Gernot Langer; Herbert Wiesinger
By a structural combination of phosphonate and bisphosphonate moieties with the vitamin D skeleton a series of new vitamin D analogs was synthesized. Derivatives with 24beta-hydroxy- or 24-keto groups exerted considerable vitamin D activities in vitro while the hypercalcemic potentials were significantly reduced as compared to 1alpha,25-dihydroxyvitamin D(3) (calcitriol). Whereas the 24-hydroxy analogs did not influence bone formation in vivo in dosages below the hypercalcemic threshold, the 24-ketones were found to induce synthesis of new bone matrix in non-hypercalcemic doses. Vitamin D bisphosphonate hybrids, on the other hand, which did not elicit substantial vitamin D activities in vitro and tend to decrease serum calcium levels in vivo clearly induced osteoid formation in rats, indicating a mechanism of action different to calcitriol.
Tetrahedron | 1995
Katica Schwarz; Günter Neef; Gerald Kirsch; Anke Müller-Fahrnow; Andreas Steinmeyer
Abstract A synthetic approach to novel 20-fluorovitamin D analogues is described. Introduction of fluorine has been performed by electrophilic fluorination followed by elaboration of biologically interesting side chain substructures.
Current Pharmaceutical Design | 2000
Andreas Steinmeyer; Gerald Kirsch; Günter Neef; Katica Schwarz
The introduction of oxygen atoms into different positions of the vitamin D side chain is described. By combining the arising 23-oxa and 25-oxa elements with other structural modifications (19-nor, iso-19-nor, 20-methyl, 20-ene, 20,21-cyclo) calcitriol analogs with remarkable levels of dissociation between beneficial acitivities on cell growth regulation and undesired hypercalcemia were identified. Structure-activity relations are elaborated in a very systematic outline of the Schering drug finding program in this particular class of vitamin D compounds.
Archive | 1992
Guenter Neef; Andreas Steinmeyer; Gerald Kirsch; Katica Schwarz; Ruth Thieroff-Ekerdt; Herbert Wiesinger; Martin Haberey
Archive | 1993
Andreas Steinmeyer; Gerald Kirsch; Günter Neef; Katica Schwarz; Ruth Thieroff-Ekerdt; Herbert Wiesinger; Martin Haberey
Archive | 1996
Gerald Kirsch; Andreas Steinmeyer; Günter Neef; Katica Schwarz; Ruth Thieroff-Ekerdt; Herbert Wiesinger; Andreas Menrad; Martin Haberey
Archive | 1993
Günter Neef; Gerald Kirsch; Andreas Stein-Eyer; Katica Schwarz; Matthias Dr. Bräutigam; Ruth Thieroff-Ekerdt; Petra Rach
Archive | 1993
Andreas Steinmeyer; G unter Neef; Gerald Kirsch; Katica Schwarz; Ruth Thieroff-Ekerdt; Herbert Wiesinger; Martin Haberey
Archiv Der Pharmazie | 1983
Walter Klose; Ulrich Niedballa; Katica Schwarz; Irmgard Dr. Böttcher